Aegon
NYSE:AEGAegon Ltd. provides insurance, pensions, retirement, and asset management services in the Americas, the Netherlands, the United Kingdom, and internationally. The company offers life, accident, property and casualty, and health insurance; annuities, retirement plans, and mutual funds; mortgage loans; and individual retirement accounts, as well as stable value, investment management, and digital banking solutions. It offers its products under the Aegon and Transamerica brands. The company was founded in 1844 and is headquartered in The Hague, the Netherlands.
Atlas Pipeline Partners
NYSE:APLTarga Pipeline Partners, L.P. (the Partnership), formerly Atlas Pipeline Partners, L.P., was formed by its parent, Targa Resources Corp., to own, operate, acquire and develop a diversified portfolio of complementary midstream energy assets. The Partnership is a provider of midstream natural gas, natural gas liquids (NGL), terminaling and crude oil gathering services in the United States. The Partnership is engaged in the business of gathering, compressing, treating, processing and selling natural gas; storing, fractionating, treating, transporting and selling NGLs and NGL products; gathering, storing and terminaling crude oil; and storing, terminaling and selling refined petroleum products.
Protalix BioTherapeutics
NYSE:PLXProtalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also developing PRX-115, a plant cell-expressed recombinant PEGylated Uricase which is in Phase I trial for the treatment of gout; and PRX-119, a plant cell-expressed PEGylated recombinant human DNase I product candidate that is in preclinical phase for the treatment of NETs-related diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz; and Chiesi Farmaceutici S.p.A. The company was incorporated in 1993 and is headquartered in Karmiel, Israel. Protalix BioTherapeutics, Inc. is a subsidiary of Protalix Ltd.
Sparta Capital
CVE:SAYSparta Capital Ltd. provides specialized energy capturing, converting, optimizing, and related services to the commercial sector. It offers viable options for helping manufacturers reduce waste, save resources, save money, and lower their carbon footprint; upcycles end-of-life electronic components; and sequesters C02 emissions through waste diversion and converts biomass waste into consumables. The company also distributes specialized photoluminescent exit signs and egress pathway marking to reduce the consumption of carbon-based electricity; and measures and monitors energy use in commercial buildings and manufacturing facilities. In addition, it delivers energy management and power quality solutions and services, including harmonic mitigation and power factor correction in industrial and commercial areas. Further, the company offers TruckSuite that provides fleet owners/operators with comprehensive maintenance, including roadside emergency assistance; emergency repair with competitive pricing, and complete warranty coverage; TreeFrog Transportation Optimization System; and Sparta Health, a streamlined process for accessing personal protective equipment. Sparta Capital Ltd. was incorporated in 1988 and is headquartered in Toronto, Canada.
